<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-09T12:01:00Z</responseDate><request verb="GetRecord" identifier="oai:riubu.ubu.es:10259/6253" metadataPrefix="dim">https://riubu.ubu.es/oai/request</request><GetRecord><record><header><identifier>oai:riubu.ubu.es:10259/6253</identifier><datestamp>2024-07-25T07:33:04Z</datestamp><setSpec>com_10259_4363</setSpec><setSpec>com_10259_5086</setSpec><setSpec>com_10259_2604</setSpec><setSpec>com_10259_4365</setSpec><setSpec>com_10259_6256</setSpec><setSpec>com_10259_9476</setSpec><setSpec>com_10259.4_106</setSpec><setSpec>col_10259_9477</setSpec><setSpec>col_10259_4366</setSpec><setSpec>col_10259_6257</setSpec><setSpec>col_10259_4364</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
<dim:field mdschema="dc" element="contributor" qualifier="author" authority="810" confidence="500" orcid_id="">Fernández Pampín, Natalia</dim:field>
<dim:field mdschema="dc" element="contributor" qualifier="author" authority="569" confidence="600" orcid_id="0000-0002-4550-4072">Vaquero Gutiérrez, Mónica</dim:field>
<dim:field mdschema="dc" element="contributor" qualifier="author" authority="2ec41a17-cbbd-4fc5-9df2-407f6aa4bdf5" confidence="600" orcid_id="">Gil Antón, Tania</dim:field>
<dim:field mdschema="dc" element="contributor" qualifier="author" authority="162" confidence="600" orcid_id="0000-0001-5617-5705">Espino Ordóñez, Gustavo</dim:field>
<dim:field mdschema="dc" element="contributor" qualifier="author" authority="625" confidence="500" orcid_id="0000-0002-9763-7328">Fernández Zoppino, Darío</dim:field>
<dim:field mdschema="dc" element="contributor" qualifier="author" authority="217" confidence="600" orcid_id="0000-0002-0817-1651">García Ruiz, Begoña</dim:field>
<dim:field mdschema="dc" element="contributor" qualifier="author" authority="83" confidence="600" orcid_id="0000-0001-9637-1209">Busto Vázquez, Natalia</dim:field>
<dim:field mdschema="dc" element="date" qualifier="accessioned">2021-12-02T09:29:29Z</dim:field>
<dim:field mdschema="dc" element="date" qualifier="available">2021-12-02T09:29:29Z</dim:field>
<dim:field mdschema="dc" element="date" qualifier="issued">2022-01</dim:field>
<dim:field mdschema="dc" element="identifier" qualifier="issn">0162-0134</dim:field>
<dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/10259/6253</dim:field>
<dim:field mdschema="dc" element="identifier" qualifier="doi">10.1016/j.jinorgbio.2021.111663</dim:field>
<dim:field mdschema="dc" element="description" qualifier="abstract" lang="en">Three neutral Pt(II) complexes containing 1-Methylimidazole and the antifungal imidazolyl drugs Clotrimazole and Bifonazole have been prepared. The general formula of the new derivatives is [Pt(κ2-(C^N)Cl(L)], where C^N stands for ppy = 2-phenylpyridinate, and L = 1-Methylimidazole (MeIm) for [Pt-MeIm]; L = Clotrimazole (CTZ) for [Pt-CTZ] and L = Bifonazole (BFZ) for [Pt-BFZ]). The complexes have been completely characterized in solution and the crystal structures of [Pt-BFZ] and [Pt-CTZ] have been resolved. Complexes [Pt-MeIm] and [Pt-BFZ] present higher cytotoxicity than cisplatin in SW480 (colon adenocarcinoma), A549 (lung adenocarcinoma) and A2780 (ovarian cancer) cell lines. [Pt-MeIm] shows the highest accumulation in A549 cells, in agreement with its inability to interact with serum albumin. By contrast, [Pt-CTZ] and [Pt-BFZ] interact with serum proteins, a fact that reduces their bioavailability. The strongest interaction with bovine serum albumin (BSA) is found for [Pt-BFZ], which is the least internalized inside the cells. All the complexes are able to covalently interact with DNA. The most cytotoxic complexes, [Pt-MeIm] and [Pt-BFZ] induce cellular accumulation in G0/G1 and apoptosis by a similar pathway, probably involving a reactive oxygen species (ROS) generation mechanism. [Pt-BFZ] turns out to be the most efficient complex regarding ROS generation and causes mitochondrial membrane depolarization, whereas [Pt-MeIm] induces the opposite effect, hyperpolarization of the mitochondrial membrane. On the contrary, the least cytotoxic complex, [Pt-CTZ] cannot block the cell cycle or generate ROS and the mechanism by which it induces apoptosis could be a different one.</dim:field>
<dim:field mdschema="dc" element="description" qualifier="sponsorship" lang="en">La Caixa Foundation (LCF/PR/PR12/11070003), Consejería de Educación-Junta de Castilla y León-FEDER (BU042U16-BU305P18), Ministerio de Ciencia, Innovación y Universidades (RTI2018-102040-B-100). M.V. is grateful for the financial support received from the Consejería de Educación-Junta de Castilla y León-FEDER (BU042U16-BU305P18).</dim:field>
<dim:field mdschema="dc" element="language" qualifier="iso" lang="es">eng</dim:field>
<dim:field mdschema="dc" element="publisher" lang="es">Elsevier</dim:field>
<dim:field mdschema="dc" element="relation" qualifier="ispartof" lang="en">Journal of Inorganic Biochemistry. 2022, V. 226, 111663</dim:field>
<dim:field mdschema="dc" element="relation" qualifier="publisherversion" lang="es">https://doi.org/10.1016/j.jinorgbio.2021.111663</dim:field>
<dim:field mdschema="dc" element="relation" qualifier="projectID">info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RTI2018-102040-B-I00/ES/PROPIEDADES ANTIMICROBIANAS DE NUEVOS COMPLEJOS ORGANOMETALICOS</dim:field>
<dim:field mdschema="dc" element="relation" qualifier="projectID">info:eu-repo/grantAgreement/Junta de Castilla y León//BU042U16</dim:field>
<dim:field mdschema="dc" element="relation" qualifier="projectID">info:eu-repo/grantAgreement/Junta de Castilla y León//BU305P18</dim:field>
<dim:field mdschema="dc" element="relation" qualifier="projectID">info:eu-repo/grantAgreement/Fundación Bancaria Caixa d'Estalvis i Pensions de Barcelona//LCF%2FPR%2FPR12%2F11070003</dim:field>
<dim:field mdschema="dc" element="rights" lang="*">Atribución 4.0 Internacional</dim:field>
<dim:field mdschema="dc" element="rights" qualifier="uri" lang="*">http://creativecommons.org/licenses/by/4.0/</dim:field>
<dim:field mdschema="dc" element="rights" qualifier="accessRights" lang="es">info:eu-repo/semantics/openAccess</dim:field>
<dim:field mdschema="dc" element="subject" lang="en">Cyclometalated platinum(II) complexes</dim:field>
<dim:field mdschema="dc" element="subject" lang="en">Clotrimazole</dim:field>
<dim:field mdschema="dc" element="subject" lang="en">Bifonazole</dim:field>
<dim:field mdschema="dc" element="subject" lang="en">Reactive oxygen species (ROS)</dim:field>
<dim:field mdschema="dc" element="subject" lang="en">Antitumoral</dim:field>
<dim:field mdschema="dc" element="subject" qualifier="other" lang="es">Química inorgánica</dim:field>
<dim:field mdschema="dc" element="subject" qualifier="other" lang="es">Bioquímica</dim:field>
<dim:field mdschema="dc" element="subject" qualifier="other" lang="en">Chemistry, Inorganic</dim:field>
<dim:field mdschema="dc" element="subject" qualifier="other" lang="en">Biochemistry</dim:field>
<dim:field mdschema="dc" element="title" lang="en">Distinct mechanism of action for antitumoral neutral cyclometalated Pt(II)-complexes bearing antifungal imidazolyl-based drugs</dim:field>
<dim:field mdschema="dc" element="type" lang="es">info:eu-repo/semantics/article</dim:field>
<dim:field mdschema="dc" element="type" qualifier="hasVersion" lang="es">info:eu-repo/semantics/publishedVersion</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>